Novo Nordisk to launch Novoeight® in the U.S. for people with hemophilia A
Novo Nordisk announced it will launch Novoeight® (Antihemophilic Factor [Recombinant]) in the U.S. for people living with hemophilia A. Novo Nordisk plans to make Novoeight® available by mid-April 2015. Novoeight® offers purity, reliability, and enhanced portability, with high storage temperature. March 26, 2015